2019 BACR Special Conference
SPONSORED BY BREAST CANCER NOW
The Sage, Newcastle Gateshead, October 9th-11th 2019
Organisers: Rob Clarke, Ingunn Holen, James Flanagan, Val Speirs
Breast cancer outcomes continue to improve due to increased awareness, early diagnosis and the introduction of novel therapies. However, there are challenges remaining for both clinicians and scientists, in particular in improving the outcome for patients’ triple negative and metastatic disease and in early detection. This meeting will cover the most recent developments in breast cancer research, with world-leading speakers providing a clinical and pre-clinical perspective to each topic. The programme includes new insights into the changing landscape of breast cancer therapies like the use of immunotherapy, CDK4/6 inhibitors, PARP inhibitors and how we can use new technologies like mathematical modelling and artificial intelligence to help improve patient care. There will also be a session focussed on DCIS, metabolomics and the role of the microbiome in breast cancer, as well as on how to study tumour cell dormancy and metastatic disease. In addition there will be a number of oral presentations selected from the submitted abstracts, offering junior investigators and students the opportunity to present their work to an expert audience. An evening program is focussed on the needs of early career researchers, how to involve patients in your research and how to obtain human tissue for your studies.
This meeting is a follow up to our successful 2015 meeting held at the same venue which was highly rated by the participants, and aims to bring together both clinicians and scientists with an interest in breast cancer research.
Confirmed topics and speakers:
The Changing Landscape of Breast Cancer – Breast tumour heterogeneity: Act locally, think globally?
Prof Momo Bentires-Alj, University Hospital, in Basel, Switzerland.
· Immunotherapy in breast cancer – where are we?
Dr Iain McPherson, The Beatson Institute, Glasgow
· Regulation of tumour cell dormancy
Dr Cyrus Ghajar, Fred Hutchinson Cancer Centre
· Immunotherapy – use in breast cancer model systems
Prof Karin de Visser, Netherlands Cancer Institute
· The science that paved the way for PARP inhibitors
Dr Helen Bryant, University of Sheffield
· Tumour cell dormancy and breast cancer recurrence
Prof Lewis Chodosh, Abramson Cancer Center, University of
· Mathematical Oncology – what it is and what it can do for you
Prof Alexander Anderson, Moffitt Cancer Centre
· Inhibiting cyclin-dependent kinases in breast cancer - CDK4/6 inhibitors and beyond
Prof Simak Ali, Imperial College London
· DCIS – recent developments in clinical research
Prof Elinor Sawyer, King College London
· Metabolomics – role in tumour progression and therapeutic
Prof Sarah-Maria Fendt, Leuwen Centre for Cancer Biology
· DCIS – to treat or not to treat?
Prof Jelle Wesseling – Netherlands Cancer Institute
· The microbiome in breast cancer – friend or foe?
Dr Stephen Robinson, University of East Anglia
· On the horizon - the next decade of breast cancer research
Prof Jo Morris, University of Birmingham
· Why we should invest in breast cancer prevention
Prof Gareth Evans, University of Manchester
Abstract Submission Deadline Extended:
30th June 2019
Up to 11 slots for oral presentations will be selected from abstracts.
(If you don't wish your abstract to be selected for oral presentation please mark appropriately, see the information attached)
Registration rates are day delegate rates only.
The BACR is working in partnership with NewcastleGateshead Convention Bureau as the official accommodation booking provider to bring you the best accommodation rates for the conference. View the full range of accommodation options to suit all budgets - book online quickly and easily www.NewcastleGateshead.com/BACR2019
Bursaries are available to breast cancer patients to attend the British Association for Cancer Research/Breast Cancer Now conference “New Developments in Breast Cancer Research – From the Lab to the Clinic”, October 9th-11th 2019, The Sage, Newcastle Gateshead.
Up to 5 bursary places will be available for anyone affected by breast cancer. This includes breast cancer patients or their carers. We are keen to encourage patient advocates or their carers to contribute to these discussions; questioning the scientific community and making patients’ voices heard at this meeting. More details and application form in the attached document [see Downloadable Documents]
Early Bird Deadline Extended: 30th June 2019
You can take advantage of discounted membership rates by joining the BACR now!
Please see our registration rates below.
Requests for refunds must be made in writing no later than 25th September 2019. No refunds will be made after this date; however substitution of delegates may be made at any time.
By registering to attend this event you are also consenting to any images that may be taken in the course of the event to be used on the Company’s Website, social media and other promotion materials and if you do not wish for your image to be used in such a way you need to let the BACR know in writing.